FDA Warns About Medline Beds After Two Deaths. The Beds Can Stay in Use Only if They Stay Unplugged.
Medline is exiting the bed market after 2 deaths and 16 serious injuries. FDA's Oct. 29 alert says to unplug its beds between adjustments.
The Food and Drug Administration on Oct. 29 issued an early alert on all Medline-brand beds and accessories, after Medline reported 2 deaths and 16 serious injuries as of Oct. 20. The beds may remain in use only under new instructions, starting with keeping them unplugged.
The action covers Medline's homecare, bariatric and long-term care beds, along with hand-control pendants, accessories, replacement parts and order packages that include a bed. Medline first notified customers on Oct. 14 and is leaving the bed business altogether.
What is the hazard?
There are two. According to FDA, the electrical parts of the bed, including the pendant, control and motor boxes and actuators, can overheat and smoke, spark, melt, burn or catch fire. The conditions FDA names include excessive loading, jammed components or motors, fluid getting into the electronics, extension cords and non-Medline pendants or accessories. Separately, accessories, a patient lying on a pendant, or loose or wobbly rails can create a risk of entrapment or asphyxiation.
Neither FDA's alert nor Medline's securities filing says which of the two hazards was involved in the deaths, and the alert does not give the number of beds in use.
The instruction that matters most is the least intuitive one: the bed is plugged in only while someone is moving it.
What does FDA tell users to do?
Medline updated its instructions on Oct. 24, and FDA's alert repeats them. Unplug the bed from the wall, plug it in only to reposition the patient, and unplug it again afterward. Do not power the bed through an extension cord. Have a second person help with use and movement when possible. Do not repair or modify the bed unless Medline directs it through an authorized process. Under those conditions, beds can stay in use until they are repaired or replaced.
Medline will repair eligible beds and offer replacement or a full or partial refund for those that are not, for products bought in the past five years. Older beds remain under the field action and the new instructions. Medline's recall line is 1-800-950-0128, option 7. Adverse events go to Medline or to FDA's MedWatch program.
How big is this for Medline?
Medline's Oct. 21 filing with the Securities and Exchange Commission puts net sales of the affected products at about $60 million for the 12 months ended June 27, 2026, and estimates costs of up to $220 million for discontinuation, inventory write-downs and customer credits. By the Script Pad's arithmetic, the exit could cost about 3.7 times a year of bed sales. The company said it does not expect a material effect on its fiscal 2026 results.
The timeline, from FDA's alert and the filing: a Feb. 13, 2026 FDA notice on a Medline homecare bed correction with updated use instructions; Oct. 14, Medline's field safety notice and market exit; Oct. 20, the injury and death count; Oct. 21, the SEC filing; Oct. 24, the revised instructions that let beds stay in service; Oct. 29, FDA's alert.
What it means in clinic
Many of these beds sit in patients' homes and in long-term care rooms rather than hospitals, so the people who must follow the instructions are family caregivers and aides. Physicians who sign home health or durable medical equipment orders, and medical directors of nursing facilities, are the ones best placed to ask whether a patient's bed is a Medline model and whether anyone has told the household to unplug it.
Patients who cannot reposition safely without powered adjustment, or who live alone, need a plan for replacement rather than a workaround. FDA uses early alerts to flag device problems before a recall is classified, as it did with the Edwards Commander delivery system in October. Our coverage of Par Health's argatroban recall shows how a product notice reaches clinical teams. This one has to reach the bedside at home.
Reported, fact-checked and edited by The Script Pad's editorial staff. See How we use AI.
This article is for professional education and does not replace clinical judgment. Treatment decisions should be based on the individual patient and current guidelines.
